Safety and performance evaluation methods for implantable cardioverter defibrillator

An implantable cardioverter defibrillator (ICD) is an active implantable medical device that is utilized in correcting atrial or ventricular fibrillation through the delivery of an electrical shock to the heart via an implanted electrode in the human body. Since an ICD is remains in the body of a patient for a long period of time and since adverse reactions to the device or defects in the device can cause critical injury to the human body, more sophisticated evaluation methods should be employed similar to the procedures used in evaluating ordinary electronic medical devices. Ensuring safety and high performance of an ICD is essential. However, much needed reference standards for the assessment of safety and efficacy of ICDs have not been defined in Korea. In this study, ICD issues were investigated, including product characteristics and permission status, to provide grounds for test items, establish methods and standards in testing and assessing the safety and performance of ICDs, which conform to international standards. Relevant documents such as those pertaining to domestic standards and FDA guidance were analyzed. Moreover, safety and performance assessment items, test standards, and test methods were successfully formulated in conformity with international standards by test validation of the proposed test methods. The output of this study is expected to contribute to the competitiveness of Korean electronic medical device industry by promoting quality and safety of ICDs.

[1]  Chan-Hyun Youn,et al.  A Novel Model for Metabolic Syndrome Risk Quantification Based on Areal Similarity Degree , 2014, IEEE Transactions on Biomedical Engineering.

[2]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[3]  S.L. Grimes The challenge of integrating the healthcare enterprise , 2005, IEEE Engineering in Medicine and Biology Magazine.

[4]  Kecheng Liu,et al.  Adaptive Requirement-Driven Architecture for Integrated Healthcare Systems , 2010, J. Comput..

[5]  Azween Abdullah,et al.  Telemedicine in a cloud — A review , 2011, 2011 IEEE Symposium on Computers & Informatics.

[6]  Ruth March,et al.  Delivering on the promise of personalized healthcare. , 2010, Personalized medicine.

[7]  Chan-Hyun Youn,et al.  Resource Reconfiguration Scheme Based on Temporal Quorum Status Estimation for Grid Management , 2005, IEICE Trans. Commun..

[8]  Sung Jin Bae,et al.  Definition and Diagnosis of the Metabolic Syndrome , 2005 .

[9]  Li-Mei Peng,et al.  An Integrated Healthcare System for Personalized Chronic Disease Care in Home–Hospital Environments , 2012, IEEE Transactions on Information Technology in Biomedicine.

[10]  A. Kuo Opportunities and Challenges of Cloud Computing to Improve Health Care Services , 2011, Journal of medical Internet research.

[11]  Chan-Hyun Youn,et al.  A method for identifying temporal progress of chronic disease using chronological clustering , 2013, 2013 IEEE 15th International Conference on e-Health Networking, Applications and Services (Healthcom 2013).

[12]  C. Aguilar-Salinas,et al.  The metabolic syndrome: a concept hard to define. , 2005, Archives of medical research.

[13]  Chan-Hyun Youn,et al.  A new grid resource management mechanism with resource-aware policy administrator for SLA-constrained applications , 2009, Future Gener. Comput. Syst..